Precision medicine is still the hottest buzzword in biomedicine, with the world rushing to grab a slice of this industry pie. Will banking on precision medicine be Taiwan's key to success?
With the major focus of BioTaiwan 2018 again being precision medicine, we are pleased to announce that we have invited Edward Rosen, President and Chief Executive Officer of Elucida Oncology, to speak on this topic. Rosen has spent more than 20 years in the industry and has extensive market understanding, product development know-how and operational strategy experience. Be prepared to expand your understanding of the precision medicine value chain!